Insider · CIK 0001451767
Roger Garceau
Files at TARA (Protara Therapeutics, Inc.). First filing -, latest -.
In brief
Roger Garceau files SEC Form 4 as director at TARA (Protara Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Roger Garceau has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | TARA Protara Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +31,000 | $0.00 | $0 | 31,000 | Jun 16, 2026 |
| Jun 12, 2025 | TARA Protara Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +24,000 | $0.00 | $0 | 24,000 | Jun 13, 2025 |
Questions about Roger Garceau
Answered from the filings on this page, as of the latest one.
Is Roger Garceau buying or selling?
Roger Garceau has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Roger Garceau's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Roger Garceau has 0.
Where does Roger Garceau file Form 4?
Roger Garceau has filed Form 4 at TARA (Protara Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.